• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Model Number 1973-03
Device Problem Entrapment of Device (1212)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/31/2023
Event Type  malfunction  
Event Description
It was reported that the ranger froze on the guidewire.A ranger paclitaxel-coated pta balloon catheter was selected for use in an angioplasty procedure.A v-18 controlwire was placed without issue.When the physician attempted to advance the ranger delivery system over the v-18, the ranger became stuck and would not advance any further once the balloon began to track over the wire.The ranger device was exchanged in order to complete the procedure.The procedure was completed, and there were no reported consequences to the patient.
 
Manufacturer Narrative
Device analysis: returned product consisted of a ranger drug coated balloon catheter.The outer shaft, inner shaft, balloon, and tip were visually and microscopically examined.Visual examination revealed buckling to the guidewire lumen 19.5cm from the tip.Microscopic and visual inspection of the remainder of the device presented no other damage or irregularities.Product analysis found damage that would have contributed to the reported event.
 
Event Description
It was reported that the ranger froze on the guidewire.A ranger paclitaxel-coated pta balloon catheter was selected for use in an angioplasty procedure.A v-18 controlwire was placed without issue.When the physician attempted to advance the ranger delivery system over the v-18, the ranger became stuck and would not advance any further once the balloon began to track over the wire.The ranger device was exchanged in order to complete the procedure.The procedure was completed, and there were no reported consequences to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER PACLITAXEL-COATED PTA BALLOON CATHETER
Type of Device
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18191928
MDR Text Key328803905
Report Number2124215-2023-65500
Device Sequence Number1
Product Code ONU
UDI-Device Identifier08714729976042
UDI-Public08714729976042
Combination Product (y/n)Y
PMA/PMN Number
P190019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number1973-03
Device Catalogue Number1973-03
Device Lot Number01426H23
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/15/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/01/2023
Initial Date FDA Received11/22/2023
Supplement Dates Manufacturer Received11/29/2023
Supplement Dates FDA Received12/15/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/01/2023
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Treatment
V-18 CONTROLWIRE; V-18 CONTROLWIRE
Patient Age66 YR
Patient SexFemale
Patient Weight68 KG
-
-